Quick Answer
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. reported Diluted EPS of $2.52 per share (loss) for fiscal year 2025.
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$2.52 | +32.1% |
| 2024 | -$3.71 | +1.3% |
| 2023 | -$3.76 | -304.3% |
| 2022 | -$0.93 | -116.6% |
| 2021 | $5.61 | +108.9% |
| 2020 | -$62.69 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.48 | +36.0% | +0.0% |
| June 30, 2025 | -$0.48 | +56.8% | -157.8% |
| March 31, 2025 | $0.83 | +13.7% | +210.7% |
| September 30, 2024 | -$0.75 | — | +32.4% |
| June 30, 2024 | -$1.11 | — | -252.1% |
| March 31, 2024 | $0.73 | — | +1142.9% |
| September 30, 2022 | -$0.07 | +90.7% | +65.0% |
| June 30, 2022 | -$0.20 | +84.0% | -11.1% |
- CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. showed an increase of +32.1% in Diluted EPS compared to the prior fiscal year.
- Over the 2020–2025 period, CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.’s diluted eps has grown by 96.0% (from $62.69 per share (loss) to $2.52 per share (loss)).
- The most recent figure is from CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: